EUVIMEDEUVIMED entdecken
Crossref

SKP2‐mediated ubiquitination and degradation of KLF11 promotes osteoarthritis via modulation of JMJD3/NOTCH1 pathway

Yuanchi Huang iD, Wenjie Pan iD, Jianbing Ma iD

The FASEB Journal · 2024

DOI: 10.1096/fj.202300664rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Yuanchi Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Joint Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi Province, P. R. China. Hauptthemen laut MEDLINE: Ubiquitination, Receptor, Notch1, S-Phase Kinase-Associated Proteins, Osteoarthritis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Shaanxi Provincial Natural Science Foundation, General Research Projects of Xi'an Municipal Health Commission, The Program for innovation Team of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is the main cause of cartilage damage and disability. This study explored the biological function of S‐phase kinase‐associated protein 2 (SKP2) and Kruppel‐like factor 11 (KLF11) in OA progression and its underlying mechanisms. C28/I2 chondrocytes were stimulated with IL‐1β to mimic OA in vitro. We found that SKP2, Jumonji domain‐containing protein D3 (JMJD3), and Notch receptor 1 (NOTCH1) were upregulated, while KLF11 was downregulated in IL‐1β‐stimulated chondrocytes. SKP2/JMJD3 silencing or KLF11 overexpression repressed apoptosis and extracellular matrix (ECM) degradation in chondrocytes. Mechanistically, SKP2 triggered the ubiquitination and degradation of KLF11 to transcriptionally activate JMJD3, which resulted in activation of NOTCH1 through inhibiting H3K27me3. What's more, the in vivo study found that KLF11 overexpression delayed OA development in rats via restraining apoptosis and maintaining the balance of ECM metabolism. Taken together, ubiquitination and degradation of KLF11 regulated by SKP2 contributed to OA progression by activation of JMJD3/NOTCH1 pathway. Our findings provide promising therapeutic targets for OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UbiquitinationReceptor, Notch1S-Phase Kinase-Associated ProteinsOsteoarthritisChondrocytesJumonji Domain-Containing Histone DemethylasesAnimalsRatsMaleSignal TransductionRats, Sprague-DawleyHumansApoptosisRepressor ProteinsKruppel-Like Transcription Factors

Stichwörter der Autor:innen

ECM degradationJMJD3KLF11NOTCH1SKP2osteoarthritis

Substanzen

Receptor, Notch1S-Phase Kinase-Associated ProteinsJumonji Domain-Containing Histone DemethylasesKdm6b protein, ratNotch1 protein, ratSKP2 protein, humanRepressor ProteinsKruppel-Like Transcription Factors

Autor:innen und Institutionen

  • Department of Joint Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi Province, P. R. China.

ORCID-Profile: Yuanchi Huang, Wenjie Pan, Jianbing Ma

Förderung

  • Shaanxi Provincial Natural Science Foundation
  • General Research Projects of Xi'an Municipal Health Commission
  • The Program for innovation Team of Shaanxi Province
  • Natural Science Foundation of Shaanxi Province

Zitieren

APA

Huang, Y., Pan, W., & Ma, J. (2024). SKP2‐mediated ubiquitination and degradation of KLF11 promotes osteoarthritis via modulation of JMJD3/NOTCH1 pathway. The FASEB Journal. https://doi.org/10.1096/fj.202300664rr

Vancouver

Huang Y, Pan W, Ma J. SKP2‐mediated ubiquitination and degradation of KLF11 promotes osteoarthritis via modulation of JMJD3/NOTCH1 pathway. The FASEB Journal. 2024. doi:10.1096/fj.202300664rr

BibTeX
@article{Huang2024,
  author = {Huang, Yuanchi and Pan, Wenjie and Ma, Jianbing},
  title = {SKP2‐mediated ubiquitination and degradation of KLF11 promotes osteoarthritis via modulation of JMJD3/NOTCH1 pathway},
  journal = {The FASEB Journal},
  year = {2024},
  doi = {10.1096/fj.202300664rr}
}
Kostenlos starten →